Bolt Share Price

Bolt Share Price

NASDAQ: BOLT | Micro Cap | Healthcare
$5.08
-$0.11 (-2.12%) Last updated on 20 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Bolt Stock Performance

Open
$5.07
Prev. Close
$5.19
Circuit Range
N/A
Day Range
$5.07 - $5.17
Year Range
$3.14 - $7.53
Volume
960
Average Traded
$5.11

Bolt Share Price Today

As of 20 November 2026, Bolt Biotherapeutics, Inc.'s share price is $5.08. The stock opened at $5.07, compared to its previous close of $5.19. During today's trading session, Bolt Biotherapeutics, Inc.'s share price traded between $5.07 and $5.17, with an average price of $5.12. Over the past 52 weeks, the stock has recorded a high of $7.53 and a low of $3.14. In terms of performance, Bolt Biotherapeutics, Inc.'s share price has declined by 2.87% over the last six months and is up 4.74% on a year-on-year basis.

Bolt Share Price Chart

Line chart of the Bolt price trend over the selected period. The price fell overall, ranging from 5.16 to 5.46, ending at 5.16.
$5.07$5.17
L
Show Current Price
H

Bolt Stock Fundamentals & Key Indicators

Market Cap
$9.50M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-11.02
Revenue (TTM)
$7.70B
Return On Equity (TTM)
-227.37%
Profit Margin
-433.51%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-8.12%

Bolt Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$2.17$2.50$0.03$0.01
Net Profit-$7.14-$6.63-$7.24-$7.72
Net Profit Margin-329.03%-265.20%-24133.33%-77200.00%
Income ChangeN/A7.14%-9.20%-6.63%

Bolt Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$5.73$7.88$7.69$7.70
Net Profit-$88.10-$69.20-$63.12-$33.38
Net Profit Margin-1537.52%-878.17%-820.81%-433.51%
Income ChangeN/A21.45%8.79%47.12%

Bolt Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets26.4948.8254.0855.06
Current Assets30.2650.81105.71172.75
Total Assets56.7599.63159.78227.81
Non Current Liabilities21.8126.5826.5933.18
Current Liabilities8.4415.8620.4623.12
Total Liabilities30.2442.4347.0456.3
Shareholders' Equity26.5157.2112.74171.51

Bolt Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-39.85-61.29-69.53-76.5
Investing44.357.5871.0457.86
Financing0.020.110.250.5

Corporate Actions

Split
Ex-date: 09 Jun 2025

About Bolt

Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company is focused on the clinical development of BDC-4182, its claudin 18.2 ISAC. Its other pipeline programs include CEA ISAC program a Boltbody ISAC targeting carcinoembryonic antigen cell adhesion molecule 5, or CEA; PD-L1 ISAC utilizes a novel human anti-PD-L1 antibody conjugated to a next-generation TLR7/8 agonist payload via a non-cleavable linker; and BDC-3042, its dectin-2 agonist antibody program, developed to repolarize critical cells in the tumor microenvironment known as tumor associated macrophages. It operates in single segment.

Bolt Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$6.30
$5.17
-20.58%
Oct 2026
$3.72
$6.51
+79.34%
Sep 2026
$3.69
$3.63
-6.68%
Aug 2026
$3.84
$3.89
-2.87%
Jul 2026
$3.83
$4.00
+4.03%
Jun 2026
$5.48
$3.85
-26.39%
May 2026
$4.82
$5.23
+9.41%
Apr 2026
$4.51
$4.78
+16.02%
Mar 2026
$4.54
$4.12
-7.62%
Feb 2026
$5.76
$4.46
-27.00%
Jan 2026
$6.02
$6.11
+12.94%
Dec 2025
$5.00
$5.41
+11.55%

Bolt Share Price FAQs